@article{97200,
  author = {Butlin CR and Maghanoy AA},
  title = {Ventajas de administrar dosis altas de clofazimina},
  abstract = {<p>Besides its role in multidrug therapy, clofazimine at higher doses is widely used for relief of Type 2 (ENL) reaction in leprosy. There is a lack of evidence from clinical trials regarding indications, optimum regimen and risk/benefit ratio to support published guidelines on its use as an anti-reaction drug. Clinical experience suggests that in adults it is safe at high doses (up to 300 mg/day) for limited periods of time but caution is needed with patients of low body weight and in those taking other drugs which may interact.</p>
},
  year = {2022},
  journal = {Revista de leprología},
  volume = {92},
  pages = {427-432},
  language = {spa},
}